Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance
Gladis Bortoletto(Veneto Institute of Molecular Medicine), A. Albertí(University of Padua), S. Bonisegna(University of Padua), L. Scribano(University of Padua), Franco Noventa(University of Padua), Silvia Mirandola(Veneto Institute of Molecular Medicine), Diego Martines(University of Padua), L Franceschini(Veneto Institute of Molecular Medicine), M. Marcolongo(University of Padua), Stefano Realdon(Veneto Institute of Molecular Medicine), Mario Plebani(University of Padua)
Cited by 31
Related Papers
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k